MecRx receives $50,000 Therapeutic Innovation Australia Pipeline Accelerator funding. MecRx receives $50,000 Therapeutic Innovation Australia Pipeline Accelerator funding.

MecRx Pty Ltd has been awarded $50,000 of Pipeline Accelerator funding by Therapeutic Innovations Australia to access ADME/PK facilities and expertise at the Centre for Drug Candidate Optimisation (CDCO), Monash University. The TIA Pipeline Accelerator funding will allow MecRx to expand the preclinical testing of its novel small molecule inhibitors of the protein Myc and advance the progression of the research program to develop a Myc inhibitor for clinical testing in cancer patients.

Further information about the Pipeline Accelerator funding program

Further information about the Centre for Drug Candidate Optimisation (CDCO), Monash University